Search Results - "Castellsagué, X."

Worldwide burden of cervical cancer in 2008 by Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., Ferlay, J.

“…The knowledge that persistent human papillomavirus infection is the main cause of cervical cancer has resulted in the development of assays that detect nucleic…”
Get full text

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age by Castellsagué, X, Muñoz, N, Pitisuttithum, P, Ferris, D, Monsonego, J, Ault, K, Luna, J, Myers, E, Mallary, S, Bautista, O M, Bryan, J, Vuocolo, S, Haupt, R M, Saah, A

“…Background: Previous analyses from a randomised trial in women aged 24–45 years have shown the quadrivalent human papillomavirus (qHPV) vaccine to be…”
Get full text

Human papillomavirus prevalence and type distribution in penile carcinoma by Miralles-Guri, C, Bruni, L, Cubilla, A L, Castellsagué, X, Bosch, F X, de Sanjosé, S

“…Penile carcinoma is an uncommon and potentially mutilating disease with a heterogeneous aetiology. Several risk factors have been established for its…”
Get more information

Immunogenicity and safety of the 9-valent HPV vaccine in men by Castellsagué, X, Giuliano, A.R, Goldstone, S, Guevara, A, Mogensen, O, Palefsky, J.M, Group, T, Shields, C, Liu, K, Maansson, R, Luxembourg, A, Kaplan, S.S

“…Highlights • We evaluated 9-valent HPV vaccine immunogenicity and tolerability in men and women 16–26 years old. • GMTs for vaccine HPV types for HM were…”
Get full text

The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium by Hashim, D., Sartori, S., Brennan, P., Curado, M.P., Wünsch-Filho, V., Divaris, K., Olshan, A.F., Zevallos, J.P., Winn, D.M., Franceschi, S., Castellsagué, X., Lissowska, J., Rudnai, P., Matsuo, K., Morgenstern, H., Chen, C., Vaughan, T.L., Hofmann, J.N., D'Souza, G., Haddad, R.I., Wu, H., Lee, Y.-C., Hashibe, M., Vecchia, C.La, Boffetta, P.

“…Poor oral hygiene has been proposed to contribute to head and neck cancer (HNC) risk, although causality and independency of some indicators are uncertain…”
Get full text

Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries by Louie, K S, de Sanjose, S, Diaz, M, Castellsagué, X, Herrero, R, Meijer, C J, Shah, K, Franceschi, S, Muñoz, N, Bosch, F X

“…Early age at first sexual intercourse (AFSI) has long been associated with an increased risk of invasive cervical carcinoma (ICC). Age at first pregnancy (AFP)…”
Get full text

HPV and cervical cancer: screening or vaccination? by Bosch, F X, Castellsagué, X, de Sanjosé, S

“…Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious…”
Get full text

SP-002: HPV by Castellsagué, X

Get full text

Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign by Reich, M., Licitra, L., Vermorken, J.B., Bernier, J., Parmar, S., Golusinski, W., Castellsagué, X., Leemans, C.R.

“…Over the past three decades, oral human papillomavirus (HPV) has been associated with an increase in the incidence of oropharyngeal squamous cell carcinoma…”
Get full text

M356 BURDEN OF DISEASE DUE TO VULVAR AND VAGINAL CANCERS IN SPAIN by Cortés, J., Hurtado, P., Castellsagué, X.

Get full text

The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain by Sandoval, M, Font, R, Mañós, M, Dicenta, M, Quintana, Mª.J, Bosch, F.X, Castellsagué, X

“…Abstract The authors carried out a hospital-based prospective study to evaluate the role of behavioral and clinical risk factors, occurring before and after…”
Get full text

SP-0489: HPV-transformation in the cervix and at non-cervical sites by Halec, G, Alemany, L, Castellsagué, X, Lloveras, B, Holzinger, D, Schmitt, M, Tous, S, Alejo, M, Waterboer, T, Bosch, F.X, De Sanjose, S, Pawlita, M

Get full text

Food groups and risk of squamous cell carcinoma of the oesophagus: a case-control study in Uruguay by DE STEFANI, E, DENEO-PELLEGRINI, H, RONCO, A. L, BOFFETTA, P, BRENNAN, P, MUNOZ, N, CASTELLSAGUE, X, CORREA, P, MENDILAHARSU, M

“…In the time period January 1998-December 2000, a case-control study on squamous cell cancer of the oesophagus was conducted in Montevideo, Uruguay. The main…”
Get full text

P29 The role of HPV in cervical lymph node metastases from squamous cell carcinoma by Schroeder, L, Holzinger, D, Baboci, L, Pawlita, M, Herold-Mende, C, Heß, J, Boscolo-Rizzo, P, Romeo, S, Alemany, L, Castellsagué, X, Quer, M, León, X, Porcel, C.L, Zgorzelski, C, Dyckhoff, G

“…Introduction Human papillomavirus (HPV) infection is a risk factor for various cancer types, including head and neck squamous cell carcinoma (HNSCC)…”
Get full text

Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report by de Sanjosé, S, Serrano, B, Castellsagué, X, Brotons, M, Muñoz, J, Bruni, L, Bosch, F X

Get full text

Prognostic value of the expression of E-cadherin and β-catenin in bladder cancer by Garcia del Muro, X., Torregrosa, A., Muñoz, J., Castellsagué, X., Condom, E., Vigués, F., Arance, A., Fabra, A., Germà, J.R.

“…The purpose of this study was to assess the prognostic effect of the expression of E-cadherin, β-catenin and CD44 adhesion molecules in bladder carcinoma. 22…”
Get full text

Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context by Siebert, U, Sroczynski, G, Baker, P, Borget, I, Castellsagué, X, Chapman, R, von Knebel-Doeberitz, M, Mortensen, G.L, La Torre, G

Get full text

Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits by NIETO, A, SANCHEZ, M. J, MARTINEZ, C, CASTELLSAGUE, X, QUINTANA, M. J, BOSCH, X, CONDE, M, MUNOZ, N, HERRERO, R, FRANCESCHI, S

“…The influence of body mass index (BMI) on oral cancer risk was evaluated in 375 incident cases and 375 age-gender-matched hospital-based controls. Low BMIs at…”
Get full text

Efficacy of the ASO4-adjuvanted HPV-16/18 vaccine in reduction of abnormal cytology, colposcopy referrals and cervical excision therapies: PATRICIA end-of-study results by Wheeler, C, Paavonen, J, Naud, P, Salmeron, J, Chow, S, Apter, D, Kitchener, H, Castellsagué, X, Teixeira, J

Get full text

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18 by Szarewski, A., Poppe, W.A.J., Skinner, S.R., Wheeler, C.M., Paavonen, J., Naud, P., Salmeron, J., Chow, S.-N., Apter, D., Kitchener, H., Castellsagué, X., Teixeira, J.C., Hedrick, J., Jaisamrarn, U., Limson, G., Garland, S., Romanowski, B., Aoki, F.Y., Schwarz, T.F., Bosch, F.X., Harper, D.M., Hardt, K., Zahaf, T., Descamps, D., Struyf, F., Lehtinen, M., Dubin, G.

“…In the Phase III PATRICIA study (NCT00122681), the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine (Cervarix®, GlaxoSmithKline Biologicals) was highly…”
Get full text